ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.060
-0.040 (-1.90%)
At close: Aug 10, 2026, 4:00 PM EDT
2.055
-0.005 (-0.24%)
After-hours: Aug 10, 2026, 7:34 PM EDT
ALX Oncology Holdings Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, ALX Oncology Holdings stock has a consensus rating of "Strong Buy" and an average price target of $4.60. The average 1-year stock price forecast is 123.30% higher than the current stock price, while the lowest is $4.00 (+94.17%) and the highest is $6.00 (+191.26%).
Price Target: $4.60 (+123.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ALX Oncology Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +94.17% | Aug 10, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 7, 2026 |
| UBS | UBS | Buy Maintains $6 | Buy | Maintains | $6 | +191.26% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +94.17% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $5 | Buy | Initiates | $5 | +142.72% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.65
from -1.66
EPS Next Year
-0.54
from -0.65
EPS and Forward PE are based on non-GAAP adjusted numbers.